Charles River Laboratories International, Inc.CRLNYSE
Loading
Operating cash flow minus capital expenditures
3Y CAGR
+20.7%/yr
vs -0.5%/yr prior
5Y CAGR
+6.4%/yr
Recent acceleration
Acceleration
+21.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $518.49M | +3.4% |
| 2024 | $501.61M | +37.3% |
| 2023 | $365.37M | +23.9% |
| 2022 | $294.91M | -44.6% |
| 2021 | $532.03M | +40.0% |
| 2020 | $380.01M | +11.6% |
| 2019 | $340.42M | +13.1% |
| 2018 | $301.09M | +28.8% |
| 2017 | $233.83M | -3.8% |
| 2016 | $243.03M | - |